Ocular Therapeutix OCUL Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $666.7M-9.5% | $737.06M+114% | $344.77M-11.9% | $391.13M+11.9% | $349.68M-10.8% | ||
| $24.35M-20.6% | $30.65M-0.4% | $30.77M+1.2% | $30.41M+20.6% | $25.22M-22.1% | ||
| $3.74M+4.9% | $3.56M+2.2% | $3.49M+14.8% | $3.04M-7.0% | $3.27M+7.5% | ||
| $706M-9.7% | $782.13M+102% | $386.98M-10.7% | $433.38M+11.8% | $387.69M-12.1% | ||
| $18.43M-6.4% | $19.68M+16.1% | $16.95M+62.1% | $10.46M-3.0% | $10.78M+14.9% | ||
| $732.53M-9.3% | $808.06M+96.7% | $410.88M-9.0% | $451.33M+11.2% | $405.92M-11.4% | ||
| $8.03M+93.2% | $4.15M-33.6% | $6.26M+6.3% | $5.89M+27.3% | $4.63M+10.8% | ||
| $47.68M-6.1% | $50.81M+3.1% | $49.29M+14.8% | $42.93M+13.2% | $37.93M-8.3% | ||
| $72.06M+1.0% | $71.34M+1.0% | $70.62M+1.0% | $69.91M+1.0% | $69.2M+1.0% | ||
| $150.96M-1.8% | $153.75M+0.7% | $152.65M+5.0% | $145.42M+3.9% | $139.99M-1.8% | ||
| $22K0.0% | $22K+22.2% | $18K+5.9% | $17K+6.3% | $16K0.0% | ||
| -$1.25B-7.7% | -$1.16B-5.9% | -$1.09B-6.8% | -$1.02B-7.1% | -$955.14M-7.2% | ||
| $581.57M-11.1% | $654.31M+153% | $258.23M-15.6% | $305.92M+15.0% | $265.93M-15.7% | ||
| $732.53M-9.3% | $808.06M+96.7% | $410.88M-9.0% | $451.33M+11.2% | $405.92M-11.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Ocular Therapeutix's total assets?
- Ocular Therapeutix (OCUL) holds $732.5M in total assets, up 80.5% year over year.
- How much debt does Ocular Therapeutix have?
- Ocular Therapeutix carries $79.5M in total debt against $581.6M of shareholders' equity, a debt-to-equity ratio of 0.14.
- How much cash does Ocular Therapeutix have?
- Ocular Therapeutix holds $666.7M in cash and equivalents.
- Can Ocular Therapeutix cover its short-term obligations?
- Its current ratio is 14.81 — current assets exceed current liabilities.
- Where does Ocular Therapeutix's balance sheet data come from?
- Every line is extracted from Ocular Therapeutix's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
